Fig. 6

Pooled risk for the composite endpoint of death, myocardial infarction, and stroke with percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) by study design. CI confidence interval, HR hazard ratio. CREDO-Kyoto 2 = the Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) PCI/CABG Registry Cohort-2; CUSTOMIZE = the Appraise a Customized Strategy for Left Main Revascularization Registry; DELTA = the drug-eluting stent for left main coronary artery disease registry; EXCEL = the Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization trial; IRIS-MAIN = Interventional Research Incorporation Society-Left MAIN Revascularization registry; MAIN-COMPARE = Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty versus Surgical Revascularization registry; PRECOMBAT = the Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease trial; SYNTAX = the other Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial